Regeneron Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 9.08 M | $7.00 B | 0.30% | 8.82% |
| BLACKROCK, INC. | 02/12/2026 | 8.74 M | $6.75 B | -1.09% | 8.49% |
| STATE STREET CORP | 02/13/2026 | 4.66 M | $3.60 B | -0.65% | 4.53% |
| DODGE & COX | 02/13/2026 | 4.60 M | $3.55 B | 1.00% | 4.47% |
| JPMORGAN CHASE & CO | 02/11/2026 | 3.94 M | $3.04 B | -3.25% | 3.77% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 2.56 M | $1.98 B | 4.36% | 2.49% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.52 M | $1.94 B | -0.65% | 2.45% |
| FMR LLC | 02/17/2026 | 2.32 M | $1.79 B | 19.82% | 2.22% |
| NUVEEN, LLC | 02/12/2026 | 2.01 M | $1.55 B | 71.07% | 1.95% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 1.95 M | $1.50 B | 142.24% | 1.89% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 1.93 M | $1.49 B | -2.28% | 1.88% |
| INVESCO LTD. | 02/19/2026 | 1.59 M | $1.23 B | 7.18% | 1.55% |
| CAPITAL WORLD INVESTORS | 02/11/2026 | 1.40 M | $1.08 B | -30.04% | 1.36% |
| MORGAN STANLEY | 02/13/2026 | 1.39 M | $1.07 B | -4.25% | 1.35% |
| NORGES BANK | 02/10/2026 | 1.31 M | $1.01 B | 100.00% | 1.27% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.16 M | $893.38 M | 0.30% | 1.12% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.10 M | $846.99 M | 15.16% | 1.07% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 995.71 K | $768.52 M | 38.03% | 0.95% |
| NORTHERN TRUST CORP | 02/17/2026 | 944.93 K | $729.37 M | -4.05% | 0.90% |
| AMUNDI | 02/17/2026 | 791.91 K | $611.25 M | 27.37% | 0.77% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 778.00 K | $600.52 M | 2.97% | 0.74% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 764.24 K | $589.90 M | 13.79% | 0.74% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 763.93 K | $589.65 M | 9.65% | 0.73% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 745.23 K | $575.22 M | 0.14% | 0.72% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 743.03 K | $573.52 M | -3.55% | 0.72% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 664.47 K | $512.88 M | 8,620.01% | 0.64% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 639.60 K | $493.69 M | 2.47% | 0.62% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 610.50 K | $471.23 M | -7.26% | 0.59% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 604.54 K | $466.63 M | -34.73% | 0.59% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 551.49 K | $425.68 M | -16.52% | 0.54% |
| FIL LTD | 02/17/2026 | 529.19 K | $408.47 M | 182.20% | 0.51% |
| JANE STREET GROUP, LLC | 02/12/2026 | 516.20 K | $398.44 M | 15.82% | 0.50% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 499.54 K | $385.59 M | 0.09% | 0.49% |
| MARSHALL WACE, LLP | 02/13/2026 | 478.55 K | $369.38 M | 23.69% | 0.47% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 478.39 K | $369.25 M | -8.68% | 0.46% |
| HOLOCENE ADVISORS, LP | 02/17/2026 | 460.72 K | $355.62 M | 203.64% | 0.45% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 445.80 K | $344.05 M | -23.73% | 0.43% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 440.84 K | $340.27 M | -7.71% | 0.43% |
| NEUBERGER BERMAN GROUP LLC | 02/13/2026 | 422.13 K | $325.83 M | 1.54% | 0.40% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 421.23 K | $325.26 M | 10.55% | 0.40% |
| CENTIVA CAPITAL, LP | 02/13/2026 | 407.10 K | $314.23 M | 1.78% | 0.39% |
| PACER ADVISORS, INC. | 02/24/2026 | 397.67 K | $306.95 M | -10.70% | 0.39% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 397.55 K | $306.86 M | 6.22% | 0.39% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 379.77 K | $293.13 M | 88.86% | 0.37% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 367.87 K | $284.72 M | 13.76% | 0.36% |
| NATIONAL PENSION SERVICE | 02/10/2026 | 360.99 K | $278.64 M | 29.79% | 0.35% |
| ROYAL BANK OF CANADA | 02/17/2026 | 345.22 K | $266.47 M | -7.47% | 0.34% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 02/17/2026 | 342.32 K | $264.23 M | -25.99% | 0.33% |
| HSBC HOLDINGS PLC | 03/20/2026 | 318.81 K | $246.22 M | -13.83% | 0.31% |
| BARCLAYS PLC | 02/13/2026 | 311.17 K | $240.18 M | -4.53% | 0.30% |
Regeneron Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 1982 institutional investors and hedge funds held shares of Regeneron Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Nuveen, LLC: 2.07 M
Bank of New York Mellon Corp: 765,411
Robeco Institutional Asset Management B.V.: 348,787
Pictet Asset Management Holding SA: 337,254
HSBC HOLDINGS PLC: 323,338
UBS Group AG: 299,979
86.65% of Regeneron Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 116.90 M shares in the last 24 months. This purchase volume represents approximately $91.37 B in transactions.